The pharmacy of the future will have to be more than a reliable place for dispensing medicines. Prevention, vaccination, diagnostics, pharmaceutical services, digital patient journeys and data-led procurement broaden the model. The uncomfortable truth, however, is that not every pharmacy will manage this transition.
The reform expands the playing field
Germany's Pharmacy Supply Development Act gives pharmacies a broader role in prevention and diagnostics. It also aims to reduce bureaucracy, strengthen night and emergency services and enable new care offers. The policy direction is clear: pharmaceutical expertise should be used more widely across healthcare, not only when medicines are dispensed.
This creates a new operating model. Consultation rooms, appointments, qualifications, hygiene, documentation, billing, digital communication and cooperation with medical practices become operational building blocks. New competencies do not automatically become new profits; every service needs a robust process.
Opportunity meets a difficult economic reality
Starting positions differ sharply. According to ABDA, the number of German pharmacy premises fell to 16,541 by the end of the first quarter of 2026, while the 2026 economic report recorded a new low in return on sales. A pharmacy already constrained by liquidity, staffing and workload cannot fund unlimited new services from existing resources.
New offers need investment in premises, staff qualifications, equipment, documentation and protected capacity. A service can be clinically valuable and politically desirable yet still fail commercially when reimbursement, utilisation and process costs do not align.
The market is moving at two speeds
Some pharmacies will actively occupy the new service landscape. They will combine medicine supply with prevention, vaccination, diagnostics, care-home services, specialisation, digital engagement and professional procurement, while measuring demand, contribution margin, staffing and quality.
Others will remain trapped in daily operations. Staff shortages, unsuitable premises, weak liquidity, unclear positioning or insufficient local demand can prevent sustainable implementation. The conservative model based almost entirely on dispensing prescription medicines is losing relative importance. It will not disappear immediately, but it is increasingly unable to support a future-ready pharmacy on its own.
Seven factors determine future viability
- Clear positioning: define the patients and care tasks for which the pharmacy is locally distinctive.
- Sound economics: calculate time, reimbursement, utilisation, premises and staffing for every new service.
- Standard processes: SOPs, QMS, appointment logic and documentation make services repeatable and auditable.
- People strategy: qualifications, responsibilities and attractive working models become part of corporate strategy.
- Digital visibility: services must be easy to find, understand and preferably book online.
- Data-led procurement: availability, terms, inventory, supply reliability and process cost are managed together.
- Cooperation: doctors, care providers, institutions and employers become care partners rather than competitors.
Transformation starts with decisions, not technology
A new device, software package or service does not solve a structural problem. First come the decisions about target group, portfolio and capacity; then process design, qualification, communication and measurement.
Owners must also choose what not to offer. A focused model suited to the location, team and patient need is more likely to succeed than an overloaded portfolio without sufficient demand.
tiger.PHARMA: turning change into a viable business model
tiger.PHARMA combines practical pharmacy and pharmaceutical-wholesale experience with strategy, QMS, procurement, data, digitalisation and operational implementation. We assess location and earnings, prioritise realistic services, develop processes and SOPs and support implementation through to measurable results. Explore consulting for pharmacy owners, pharmacy QMS and pharmaceutical data and smart sourcing.
Trusted sources
- German Federal Ministry of Health: Bundestag approves pharmacy reform
- German Federal Ministry of Health: Pharmacy Supply Development Act
- ABDA: Pharmacy Economic Report 2026
Analysis current at 18 August 2026. Legal feasibility and economic suitability must be assessed for the individual pharmacy.